Funder: GBS/CIDP Foundation International
Due Dates (Anticipated): January 2027 (Full application) | November 2027 (Letter of intent)
Funding Amounts: Discovery: up to $100,000 annually for two years; Elevation: up to $50,000 for one year
Summary: Supports research on GBS, CIDP, MMN, and related variants to improve diagnosis, treatment, and knowledge toward an eventual cure.
Key Information: Only Discovery Award and Elevation Award letters of intent and applications are accepted in 2027.
Description
GBS/CIDP Foundation International funds basic and translational research that expands understanding of Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and related disorders. Its interests include demyelinating and axonal forms of GBS, Miller Fisher syndrome, and multifocal motor neuropathy (MMN). The Foundation has committed $8 million to research and awards multiple grants annually.
Research priorities include faster diagnosis, mechanisms involved in disease pathogenesis, and more effective treatments that limit disease progression, prevent complications, and reduce long-term adverse effects. The program also supports educational and communication projects that inform patients and families about the Foundation’s availability. Discovery Awards address complex research questions, while Elevation Awards support smaller projects or portions of larger projects.
